Zanubrutinib Monotherapy in Relapsed/Refractory Central Nervous System Lymphoma
- First Posted Date
- 2021-11-11
- Last Posted Date
- 2022-08-03
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05117814
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Gut Microbiota in ITP
- Conditions
- ITP
- First Posted Date
- 2021-11-11
- Last Posted Date
- 2022-01-12
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 240
- Registration Number
- NCT05118126
- Locations
- 🇨🇳
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China
A Comparative Study of Rimazolam and Propofol Combined With Etomidate in Gastroenteroscopy in Elderly Patients
Not Applicable
Completed
- Conditions
- Remimazolam BesylateEtomidate Combined With PropofolElderly PatientsGastrointestinal Endoscopy
- Interventions
- First Posted Date
- 2021-11-02
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT05103696
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome
- First Posted Date
- 2021-10-21
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT05087589
- Locations
- 🇨🇳
Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, Beijing, China
Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section
Phase 4
Completed
- Conditions
- Cesarean Section Complications
- Interventions
- First Posted Date
- 2021-10-20
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 124
- Registration Number
- NCT05084599
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas
- First Posted Date
- 2021-10-15
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05079022
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults
- First Posted Date
- 2021-10-01
- Last Posted Date
- 2021-10-01
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT05064748
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
China Atopic Dermatitis Registry Study
Recruiting
- Conditions
- Dermatitis, Atopic
- Interventions
- Other: No intervention
- First Posted Date
- 2021-08-26
- Last Posted Date
- 2021-08-26
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT05023668
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Retrospective Survey of Hyperkalemia in Hemodialysis
- Conditions
- Hemodialysis Complication
- First Posted Date
- 2021-08-25
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05020717
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
Early Phase 1
Not yet recruiting
- Conditions
- T-cell Non-Hodgkin's Lymphoma
- Interventions
- Drug: CD147- CAR T cells
- First Posted Date
- 2021-08-19
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT05013372
© Copyright 2025. All Rights Reserved by MedPath